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1ABSTRACT
We examined the impact of Sindbis virus (SIN) infection on cell cycle progression in
a cancer cell line, HeLa, and a non-cancerous cell line, Vero. Cell cycle analyses
showed that SIN infection is able to alter the cell cycle progression in both HeLa and
Vero cells, but differently, especially during the early stage of infection. SIN infection
affected the expression of several cell cycle regulators (CDK4, CDK6, cyclin E, p21,
cyclin A and cyclin B) in HeLa cells and caused HeLa cells to accumulate in S phase
during the early stage of infection. Monitoring SIN replication in HeLa and Vero cells
expressing cell cycle indicators revealed that SIN which infected HeLa cells during
G1 phase preferred to proliferate during S/G2 phase, and the average time interval for
viral replication was significantly shorter in both HeLa and Vero cells infected during
G1 phase than in cells infected during S/G2 phase. The expression of p53 was affected
at the later stage of infection, and p53 expression may be involved in the efficient
replication of SIN. The alteration of cell cycle progression that SIN infection causes
might have an implication regarding the oncolytic feature of SIN.
2Introduction
Sindbis virus (SIN) is an RNA virus belonging to the Alphavirus genus in the
Togaviridae virus family. SIN is transmitted to birds and mammals by mosquito bites
and subsequently spreads throughout the body through the bloodstream (Griffin,
2001). SIN infection induces no or only mild symptoms (fever, rash, and arthralgia) in
humans (Jan and Griffin, 1999). SIN has the potential to induce apoptosis in infected
mammalian cells, but establishes a non-cytolytic persistent infection in arthropod cells
(Jan and Griffin, 1999; Moriishi et al., 2002). In addition, the 67-kDa, high-affinity
laminin receptor has been identified as a surface attachment factor that mediates SIN
infection of mammalian cells (Wang et al., 1992), and is highly expressed in various
human cancers (van den Brûle et al., 1996; al-Saleh et al., 1997).
We reported previously that SIN has oncolytic features and demonstrates
antitumoral effects in various cancers, including cervical and ovarian cancer (Unno et
al., 2005), and human oral squamous carcinoma cells (Saito et al., 2009b).
Replication-defective SIN vectors have also been developed to target and eradicate
tumors (Tseng et al., 2002; Yamanaka, 2004). To increase anti-tumor potency, SIN
vectors expressing foreign genes, such as cytokines like IL-12 (Tseng et al., 2004) and
the herpes simplex virus type-1 thymidine kinase (TK) gene (Tseng et al., 2006, 2009),
have been explored.
As an oncolytic virus, the favorable features of SIN include rapid production of
high-titer virus, efficient infection of a variety of cancer cells, and a high RNA
replication rate in the cytoplasm (Saito et al., 2009a). The preferable characteristics of
3SIN for cancer therapy might be attributed to the combination of favorable viral
growth and the uncontrolled cell proliferation of cancer cells, including deregulation
of the cell cycle. In normal cells, cell cycle regulator proteins, cyclin-dependent
protein kinases (CDKs), cyclins, and CDK inhibitory proteins regulate progression
through G1, S, G2 and M phases in the cell cycle. Controls by these regulators are
often disturbed in cancer cells, which tend to remain in cycle (Sherr, 1996). Many
viruses can affect the cell cycle progression of host cells to favor viral replication.
Regarding DNA viruses, such as simian virus 40, adenovirus, and papillomavirus,
infected cells are promoted into S phase (reviewed by Op De Beeck and Caillet-
Fauquet, 1997). Several RNA viruses also reportedly affect the cell cycle (reviewed
by Emmett et al., 2005). Measles virus infection results in a G0 block (Naniche et al.,
1999), and the paramyxovirus simian virus V protein is known to prolong the cell
cycle by delaying the G1/S transition and suppressing progression through S phase
(Lin and Lamb, 2000). Recently, malignant glioma cells infected with an RNA virus,
alphavirus M1, were shown to accumulate in S phase by down-regulating p21 protein
(Hu et al., 2009). The interaction between SIN replication and the host cell cycle has
not been studied in detail, particularly in the context of oncolysis.
In this study, we analyzed the dynamics of cell cycle phases of HeLa and Vero
cells infected with SIN in order to elucidate the interaction between SIN replication
and the host cell cycle. SIN infection resulted in several significant alterations of cell
cycle progression that differed between HeLa cells and Vero cells. Further analysis of
cell cycle regulators indicated that SIN infection affected the expression of key cell
4cycle regulators in HeLa cells. Experiments with cells expressing the cell cycle
indicators fluorescent ubiquitination-based cell cycle indicator (Fucci)-orange and
Fucci-green and SIN expressing blue fluorescence protein (BFP) revealed that SIN
which infected HeLa cells during G1 preferred to replicate during S/G2 phase. For
both HeLa and Vero cell lines, the average interval for viral replication was shorter in
cells infected during G1 than in cells infected during S/G2. In this study, SIN infection
was able to alter the cell cycle progression of infected cancer cells and exhibited a
preference for the timing of viral replication among the cell cycle phases.
5Materials and Methods
Cell lines
HeLa cells were obtained from the American Type Culture Collection (ATCC;
Rockvile, MD). HSC-4 cells were derived from the Human Science Research
Resources Bank (Osaka, Japan). Vero cells and human fibroblast cells were
laboratory stock. Cells were grown in Dulbecco’s modified Eagle’s medium (DMEM;
Sigma) with 10% fetal bovine serum (FBS) at 37ºC in 5% CO2.
Viral stocks and construction of recombinant virus
We used the laboratory stock of the AR339 strain of SIN. The plasmid pTR339-
GFP-2A was kindly provided by Dr. Hans W. Heidner (University of Texas, San
Antonio, TX; Thomas et al., 2003). To substitute the BFP gene for the GFP gene in
the pTR339-GFP-2A plasmid, 2.5 kbp of PCR product containing GFP-2A was
amplified from pTR339-GFP-2A and ligated into the pCR2.1-Topo vector
(Invitrogen). Insertion of the fragment was confirmed by sequencing. Next, the
fragment was re-cloned into the pGEM-3Z vector between the EcoRI (5’) and BamHI
(3’) restriction sites. Then, reverse PCR without the GFP gene was performed using
KOD-plus enzyme (Toyobo Life Science Department) to generate the pGEM-2A
fragment. Meanwhile, the BFP gene was amplified using PCR and the KOD-plus
enzyme, with primers containing 15-bp extensions homologous to the pGEM-2A
fragment ends. The pGEM-2A and BFP fragments were ligated using the In-fusion
HD Cloning Kit (Clontech) to yield pGEM-BFP-2A. A 2460-bp fragment containing
a part of nsp4 and the full capsid was ligated into pGEM-BFP-2A between the EcoRI
6(5’) and NruI (3’) restriction sites to generate pGEM-C-BFP-2A. Next, pTR339-GFP-
2A was digested with HpaI (5’) and BssHII (3’) restriction enzymes, and GFP was
replaced with BFP from pGEM-C-BFP-2A to yield pTR339-BFP-2A.
RNA transcription and transfection
For in vitro transcription, pTR339-BFP-2A plasmid was purified using the
HiSpeed Plasmid Midi Kit (Qiagen), linearized with XhoI (Biolab), and transcribed in
vitro with the RiboMAXTM Large-Scale RNA production system-SP6 kit (Promega).
We used 2 μL of the transcription product per 2 μL lipofectamineTM 2000 to transfect
Vero cells. Three days after transfection, the virus generated from the pTR339-BFP-
2A, TR339-BFP-2A, was collected and frozen at -80ºC. TR339-BFP-2A was
propagated in Vero cells maintained in DMEM with 10% FBS at 37ºC in 5% CO2.
Viral titers were determined by plaque assays using monolayers of Vero cells.
Generation of HeLa and Vero cells that express Fucci-G1 orange and Fucci-
S/G2/M green
To obtain HeLa and Vero cells that stably express Fucci-G1 orange and Fucci-
S/G2/M green, we successively introduced two plasmids, pFucci-G1 orange and
pFucci-S/G2/M Green-hyg (Amalgaam), into HeLa cells and Vero cells. After being
pre-cultured in 6-well dishes, HeLa and Vero cells were transfected with 5 μg of
pFucci-G1 orange per 2 μL of lipofectamine 2000TM. After overnight incubation of
transfected cells, the cells were passaged from 6-well dishes to 10-cm dishes. To
obtain stable transformants, the transfected Vero and HeLa cells were selected in
medium containing 600 μg/mL and 400 μg/mL Geneticin (G418) (Invitrogen),
7respectively. After 7 to 10 days of selection, the colonies that exhibited orange
fluorescence in the nuclei were picked up and cultured in medium containing 200
μg/mL G418 for further selection. The HeLa and Vero cells that stably expressed
Fucci orange were obtained from the selected colonies. Then, the HeLa and Vero cells
that stably expressed Fucci-G1 orange were transfected with pFucci-S/G2/M Green-
hyg. The transfected Vero and HeLa cells were selected in 250 μg/mL and 200 μg/mL
hygromycin B (Wako), respectively. The colonies that exhibited both orange and
green nuclei were picked up and cultured to obtain stably transformed HeLa-Fucci
and Vero-Fucci cell lines.
Imaging of cultured cells
Cells were grown on a 35-mm dish in DMEM with 10% FBS. TR339-BFP-2A
virus was adsorbed with cells for 30 min at 5 MOI for HeLa-Fucci cells and 1 MOI
for Vero-Fucci cells. After incubation at 37ºC in 5% CO2 for 1.5 hours, cells were
subjected to long-term, time-lapse imaging using a computer-assisted fluorescence
microscope (Olympus, FV10i) at 37ºC in 5% CO2. Images were recorded every 30
min. Three filter cubes were chosen for fluorescence imaging: mKusabira-orange
(excitation wavelength 548 nm, emission wavelength 559 nm) to observe Fucci
orange, Azami Green (excitation wavelength 493 nm, emission wavelength 505 nm)
to observe Fucci green, and Blue-Narrow (excitation wavelength at 405 nm, emission
wavelength 420 - 460 nm) to observe BFP. We used Fluoview version 3.1 (Olympus)
for image acquisition and analysis.
Western blotting
8Cells were collected and washed twice with PBS, and an equal number of infected
and mock-infected cells were resuspended in an equal volume of M-PER@
Mammalian Protein Extraction Reagent (Thermo) with a cocktail of protease inhibitor
(Sigma-Aldrich) and mixed gently for 10 minutes. Lysates were centrifuged at 14,000
× g for 15 min. Equal volumes of extracted protein were loaded onto SDS-
polyacrylamide gels (Atto Corporation), transferred onto PVDF membranes (Trans-
Blot TurboTM Transfer Pack, BIO-RAD), and analyzed with antibodies. Rabbit anti-
CDK2, rabbit anti-pCDK2 (Thr 160), rabbit anti-cyclin B1, rabbit anti-p21Waf1/Cip1,
mouse anti-CDK4, mouse anti-CDK6, rabbit anti-p-cdc2 (Y15), mouse anti-cyclin D1,
rabbit anti-RARP, and rabbit anti-cleaved caspase-3 were obtained from Cell
Signaling Technology. Rabbit anti-cyclin A, mouse anti-cyclin E, mouse anti-Cdc25A,
and rabbit anti-p53 were obtained from Santa Cruz Biotechnology. Rabbit anti-β-actin
and rabbit anti-caspase-3 were purchased from Abcom. Rabbit anti-capsid was
prepared in our laboratory (Unno et al., 2005).
Cell cycle analysis
Cells were collected and washed twice with PBS. Next, cells were treated with
reagents from the CycleTEST™ PLUS DNA Reagent Kit (Becton Dickinson and
Company) and analyzed on a BD AccuriTM C6 Flow Cytometer (Becton Dickinson
and Company) equipped with FACScan’s fluorescence 2 (FL2) detector. The
collected data was analyzed using FlowJo 7.6.5 (TreeStar Company).
Statistical analysis
9All values were expressed as mean ± SD. The Mann-Whitney U-test was used to
compare the time of BFP fluorescence appearance and the interval between BFP
appearance and apoptosis. Significant differences between expected frequencies and
observed frequencies were tested using the chi-square test. Statistical analyses were
performed using the software Statcel2, version 2 (OMS, Tokyo, Japan). Values of P <
0.05 were considered statistically significant.
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Results
Effects of SIN infection on cell cycle progression in HeLa and Vero cells
Many viruses can affect the cell cycle progression of host cells in favor of viral
replication (Emmett et al., 2005). The interactions between SIN replication and host
cell cycle have not been studied in detail, particularly in the context of oncolysis. To
investigate the impact of SIN infection on cell cycle progression, we used
fluorescence-activated cell sorting (FACS) analysis to assess the effect of SIN
infection on the distribution of HeLa and Vero cells in each phase of the cell cycle.
Cells infected with 1 MOI of SIN or mock-infected were subjected to FACS analysis
at 2, 4, 7, and 15 hours post-infection (hpi) in HeLa cells and at 2, 4, 7, and 14 hpi in
Vero cells. SIN infection significantly altered the cell cycle profile in HeLa cells
(primary data are shown in Fig. 1A, and the time course of the proportion of cells in
G0/G1, S, and G2/M phases are shown in Fig. 1B). The proportion of HeLa cells in S
phase increased and proportions of HeLa cells in G0/G1 and G2/M decreased by 4 hpi,
suggesting that SIN infection might simultaneously promote cell entry into S phase
and prevent exit from S phase (Fig. 1A). The proportions of SIN-infected cells in each
stage of the cell cycle approached the respective proportions of mock-infected cells by
7 hpi (Fig. 1B). Then, the proportions of infected cells in G0/G1 and S phases
increased and decreased, respectively, suggesting that cell cycle progression from G1
to S phase was blocked and that cells accumulated in G0/G1 at the later stage of
infection.
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In contrast, SIN infection caused little effect on the cell cycle progression of Vero
cells during the early stage of infection (Fig. 1C). However, at the later stage of
infection (by 14 hpi), the proportion of infected cells in S phase had increased and the
proportions of infected cells in G0/G1 and G2/M had decreased (Fig. 1D).
Effects of SIN infection on the expression of cell cycle regulators in HeLa cells
FACS analysis demonstrated that SIN infection affected cell cycle progression in
both HeLa and Vero cells, but differently. To characterize the molecular basis for the
effects of SIN infection on the cell cycle in HeLa cells, we examined the levels of key
cell cycle regulatory proteins. These cellular proteins were collected from mock- and
SIN-infected HeLa cells at 2, 4, 7, and 15 hpi, and protein levels were measured using
Western blotting (Fig. 2).
Because the cyclin D/CDK4 (CDK6) complex is active during early G1 and
regulates the progression of G1, we examined the expression of these proteins and
their regulators in infected HeLa cells. Although cyclin D1 expression was not
affected by SIN infection by 7 hpi, cyclin-dependent kinases CDK4 and CDK6 were
both expressed at higher levels in SIN-infected cells at 4 and 7 hpi (Fig. 2A). The
elevated expression of CDK4 and CDK6 may account for the acceleration of G1
progression, followed by the decreased proportion of G0/G1 cells observed by FACS
analysis in HeLa cells at 4 hpi.
During late G1, the activated cyclin E/CDK2 complex promotes the G1/S transition
by phosphorylating pRB (Pestell et al., 1999). Cyclin E, the overexpression of which
shortens the duration of G1 phase independently of pRB (Resnitzky et al., 1994;
12
Ohtsubo et al., 1995; Lukas et al., 1997), increased significantly at 4 and 7 hpi in SIN-
infected HeLa cells (Fig. 2B). The expression pattern of cyclin E in SIN-infected cells
was similar to the expression patterns of CDK4 and CDK6. Total CDK2 expression in
SIN-infected cells was not affected by the infection (Fig. 2B). Because CDK2 activity
is regulated by phosphorylation at Thr160 and activated by Cdc25A-mediated
dephosphorylation of Thr14 and Tyr15 (Gu et al., 1992), we examined the expression
of p-CDK2 (Thr160) and Cdc25A. Although p-CDK2 (Thr160) levels were not
affected by 7 hpi, Cdc25A was expressed at a higher level in SIN-infected cells at 7
hpi (Fig. 2B). Meanwhile, the expression of p21, which binds to and inhibits the
cyclin E/CDK2 complex (Chen et al., 1995; Goubin and Ducommun, 1995), was
decreased significantly in SIN-infected cells at 4 hpi (Fig. 2B). Taken together, the
up-regulation of cyclin E and Cdc25A and down-regulation of p21 were thought to
shorten G1 and promote the G1/S transition, in cooperation with CDK4/6-promoted G1
progression. The alterations of cyclin E, Cdc25A, and p21 expression by SIN
infection were considered consistent with the decrease of cells in G1 phase and the
increase of cells in S phase observed by FACS analysis.
To determine whether the decreased p21 expression at 4 hpi and the increased
Cdc25A expression at 7 hpi in SIN-infected cells were the result of transcriptional
regulation by p53 (Demidova et al., 2009; Shen and Huang, 2012), we measured the
expression of p53. By 4 hpi, p53 expression was not affected by SIN infection,
suggesting that the decrease of p21 at 4 hpi might be independent of p53 expression
(Fig. 2B). On the other hand, the down-regulation of p53 expression at 7 hpi in SIN-
13
infected cells was considered consistent with the increase of Cdc25A at 7 hpi, because
p53 inhibits Cdc25A transcription through the activation of ATF3 (Demidova et al.,
2009).
Cyclin A associates with CDK2 and regulates the progression of S phase (Woo and
Poon, 2003). We observed suppressed cyclin A expression in SIN-infected cells at 4
hpi (Fig. 2C). This might cause retardation of S phase, and was consistent with the
decrease of cells in G2/M phase and the increase of cells in S phase in SIN-infected
HeLa cells observed by FACS analysis.
Entry into M phase is signaled by the accumulation of cyclin B-cdc2, and the
activation of cdc2 requires dephosphorylation at Tyr15 and Thr14 (Dunphy 1994).
Therefore, we measured the levels of cyclin B1 and phosphorylated p-cdc2 (Tyr 15)
protein in SIN-infected HeLa cells. Cyclin B1 expression was suppressed in SIN-
infected cells (Fig. 2C), indicating that SIN infection might block the cell cycle
transition through the G2/M checkpoint. Failure to pass the DNA replication
checkpoint results in the inhibition of cdc25C activity, in turn leading to inhibition of
the dephosphorylation of cdc2 (Zeng et al., 1998). Therefore, higher levels of p-cdc2
protein (the inactive form of the protein) in SIN-infected cells at 4 hpi (Fig. 2C)
agreed with the temporal accumulation of cells in S phase at 4 hpi observed by FACS
analysis.
At 15 hpi, the expression of cyclin D1 in infected cells was undetectable, and both
CDK4 and CDK6 were expressed at low levels (Fig. 2A). The suppression of cyclin
D1, CDK4, and CDK6 at 15 hpi suggested that the progression of G1 phase should be
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blocked during the later stage of infection. The expression of cyclin E, p-CDK2, and
Cdc25A in infected cells also decreased at 15 hpi (Fig. 2B), suggesting that the G1/S
transition should also be blocked. The suppressed expression of these proteins at 15
hpi was consistent with the increased proportion of SIN-infected HeLa cells in G1
phase at 15 hpi observed by FACS analysis. The suppression of p21 expression in
infected cells was observed by 15 hpi, and might be caused by decreased p53
expression (Fig. 2B). By 15 hpi, the expression of cyclin A, which regulates the
progression of S phase, had decreased in infected cells (Fig. 2C), suggesting that cells
in S phase might be arrested during the later stage of infection.
To examine the function and time course of viral proliferation, we analyzed the
expression of the capsid protein and two apoptotic indicators: cleaved caspase-3 and
PARP fragment. The capsid protein was detected at 7 hpi (Fig. 3), indicating that
SIN-induced promotion to S phase and the accumulation of cells in S phase occurred
before structural proteins were expressed. Protein bands representing cleaved caspase-
3 (19 kDa) and cleaved PARP fragment (89 kDa) were observed at 15 hpi (Fig. 3),
indicating that apoptosis was induced at 15 hpi. The observation that apoptosis
occurred at 15 hpi excluded the effect of SIN-induced apoptosis on the expression of
cell cycle regulators during the early stage of infection and explained the reduced
expression of cell cycle regulators at 15 hpi.
Viral replication and cell cycle phases in HeLa-Fucci and Vero-Fucci cells
FACS analysis and the effect of SIN infection on key cell cycle regulators
demonstrated that HeLa cells were promoted into S phase and temporally arrested in
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S phase during the early stage of infection, but Vero cells were not. The differences in
the cell cycle progression of HeLa and Vero cells after SIN infection might reflect
differences between cancer cells and non-cancerous cells regarding the status of the
cell cycle. Such differences might cause variations in viral replication depending on
cell cycle phase. To test this hypothesis, we simultaneously monitored SIN replication
and a cell cycle indicator, Fucci, in HeLa and Vero cells.
We established HeLa-Fucci and Vero-Fucci cell lines by introducing pFucci-G1
orange and pFucci-S/G2/M Green-hyg successively into Vero and HeLa cells. In both
cell lines, Fucci effectively labeled individual nuclei in G1 phase as orange and those
in S/G2/M phases as green (Sakaue-Sawano et al., 2008). To label viral replication,
HeLa-Fucci and Vero-Fucci were infected with TR339-BFP-2A, which contains the
BFP gene between capsid and E3, and co-expresses BFP with viral structural proteins.
After viral infection with TR339-BFP-2A, HeLa-Fucci and Vero-Fucci cells were
imaged using a computer-assisted fluorescence microscope (Olympus, FV10i).
Images were recorded every 30 min until most cells exhibited apoptosis.
The serially collected images of 217 infected HeLa-Fucci and 190 infected Vero-
Fucci cells were traced and analyzed regarding cell cycle phases, the timing of the
appearance of BFP fluorescence, and the time interval between BFP appearance and
apoptosis. As shown in Table 1, the proportions of infected HeLa cells in G1 and
S/G2/M phase at 2 hpi were 41% and 59%, respectively; these were equal with the
proportions of total cells in G1 (40%) and S/G2/M phase (60%), respectively. The
proportions of infected Vero cells in G1 (57%) and S/G2/M phases (43%) also
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exhibited no obvious difference from the proportions of total cells in G1 (51%) and
S/G2/M phase (49%), respectively. These results suggested that HeLa-Fucci and
Vero-Fucci cells in G1 and S/G2/M phase are equally susceptible to SIN infection.
The proportions of BFP-expressing cells in respective cell cycle phases were as
follows: HeLa-Fucci, 52% in G1 and 48% in S/G2/M; Vero-Fucci, 51% in G1 and 49%
in S/G2/M. When the BFP-expressing cells were traced back to 2 hpi, the respective
proportions of clones in cell cycle phases G1 and S/G2/M were 41% and 59% for
HeLa-Fucci and 47% and 53% for Vero-Fucci cells. Almost all cells underwent
apoptosis during the same cell cycle phase at which BFP was expressed.
Cells infected during G1 phase expressed BFP during G1 or S/G2 phase, and cells
infected during S/G2 phase expressed BFP during S/G2 or after exiting M phase (Fig.
4A-D). The mean interval between adsorption and BFP expression in cells infected
during G1 was 9.3 h for HeLa cells and 8.9 h for Vero cells. The corresponding
intervals were significantly longer for HeLa-Fucci and Vero-Fucci cells infected
during S/G2/M (10.4 h and 10.2 h, respectively, Mann-Whitney U-test; P < 0.05)
(Table 2). Apoptosis was always observed a few hours after the appearance of BFP
(Table 2). The mean intervals between BFP appearance and apoptosis differed
between cell lines (HeLa-Fucci: 3.8 hours; Vero-Fucci: 4.7 hours), but did not differ
significantly between cells infected during G1 phase and those infected during S/G2/M
phase (Table 2). During the interval between BFP appearance and apoptosis, the color
of Fucci changed only in a few cells that expressed BFP during M phase, indicating
that most cells underwent cell cycle arrest once the virus started to replicate.
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Sixty-nine percent of HeLa-Fucci cells infected with SIN during G1 expressed BFP
after entering S/G2; in contrast, 31% of cells infected during G1 phase expressed BFP
during G1 phase (Fig 5A). The preference for viral replication during S/G2 phase in
HeLa-Fucci cells was consistent with the promotion of the G1/S phase transition by
infection. Fewer Vero-Fucci cells infected during G1 (52%) than HeLa-Fucci cells
infected during G1 expressed BFP during S/G2 (chi-square test; P < 0.05) (Fig. 5B).
Quite a few cells expressed BFP during M phase in both HeLa-Fucci and Vero-Fucci
cells. The mean intervals between adsorption and BFP expression were significantly
longer for cells that were infected during S/G2 phase and progressed through M phase
than for cells that did not progress through M phase (Mann-Whitney U-test; P < 0.05),
suggesting that viral proliferation might be suspended during M phase.
SIN infection affects p53 expression differently in Vero cells, human fibroblasts,
and HSC-4 cells
Generally, SIN infection causes cytopathic effects and apoptosis in mammalian
cells (Frolov and Schlesinger, 1994). However, in some cell lines (e.g., HSC-4 cells),
SIN can grow to a high titer with low cytopathogenicity (Saito et al., 2009b). In our
results, the down-regulation of p53 and viral capsid expression were simultaneously
observed in SIN-infected HeLa cells. Because p53 is an important regulator of
apoptosis, we hypothesized that p53 might play an important role in the resistance of
cancer cells (e.g., HSC-4 cells) to SIN-induced apoptosis. To test this hypothesis, we
examined the effect of SIN infection on the expression of p53 and capsid protein in
Vero cells, human fibroblasts, and HSC-4 cells.
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In SIN-infected Vero cells, p53 levels decreased significantly at 4 hpi, followed by
capsid protein expression at 7 hpi (Fig. 6A). In human fibroblasts, p53 expression
decreased strikingly as the capsid protein was expressed at 15 hpi (Fig. 6B). In
contrast, we observed a remarkable increase of p53 in HSC-4 cells (which harbor a
mutant p53) as the capsid protein was expressed (Fig. 6C). Because p53 is a
dominant-negative mutant in HSC-4 cells (Ichwan et al., 2006), the different response
of p53 to SIN infection in HSC-4 cells may be attributable to the integrity of p53
protein. In addition, the resistance of HSC-4 cells to the oncolytic activity of SIN
suggested a significant role for p53 in SIN-induced cytotoxicity.
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Discussion
Both DNA and RNA viruses can alter the cell cycle to create a cellular
environment that favors efficient replication (Reviewed by Emmett et al., 2005). In
the present study, we observed that SIN infection altered the cell cycle progression in
HeLa and Vero cells; however, these cell lines’ responses to SIN infection differed
during the early stage of infection. SIN infection caused HeLa cells to accumulate in
S phase, with the proportion of cells in G1 and G2/M phases decreasing by 4 hpi.
Consistently, SIN infection of HeLa cells affected the expression of CDK4 and CDK6
(G1 phase regulators), cyclin E and p21 (G1/S transition regulators), cyclin A (an S
phase regulator), and cyclin B (a G2/M transition regulator). Changes in the
expression of cell cycle regulators during the early stage of SIN infection were
considered to contribute to the promotion of the G1/S transition and cell cycle
retardation in S phase.
Using HeLa-Fucci cells infected with TR339-BFP-2A, we traced individual cells
from infection to apoptosis. We confirmed that SIN, which infected HeLa cells but
not Vero cells during G1, preferred to proliferate during S/G2, and the average length
of time for viral replication was shorter in cells infected during G1 than in cells
infected during S/G2/M phase. Because cells that expressed BFP during M phase were
rare in Fucci expression experiments, viral proliferation appeared to be suspended
during M phase. The suspension of viral proliferation in M phase might explain why
the cells that were infected during S/G2 and progressed through M took longer to
express BFP.
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A number of proteins involved in cell cycle control, including CDK2, p53, and p21,
are distributed in the nucleolus, and their residence is dependent on cell cycle
progression (Andersen et al., 2005). RNA viruses can hijack the nucleolus to usurp
host cell functions and recruit nucleolar proteins to facilitate viral replication
(reviewed by Hiscox, 2007). The alphavirus capsid protein and non-structural protein
nsp2 have been shown to localize to the nucleoli of infected cells (Michel et al., 1990;
Rikkonen et al., 1992). It remains to be determined whether these viral proteins
located in the nucleolus affect the expression of cell cycle regulators, such as CDK4,
CDK6, cyclin E, p21, and cyclin A.
Given that 80-90% of cellular RNA and protein synthesis is inhibited a few hours
after infection by SIN (Gorchakov et al., 2005), it is noteworthy if the inhibition of
RNA and protein synthesis is able to affect the expression of cell cycle regulators and
cell cycle progression. In this study, after HeLa cells were infected with SIN, the
expression of most cell cycle regulators exhibited no decrease at 7 hpi, but had
decreased or disappeared by 15 hpi. Cell-cycle analyses between 7 and 15 hpi
indicated that cell cycle progression still took place in infected HeLa cells. In
experiments using Fucci-expressing cells, more than one-half of infected HeLa-Fucci
and Vero-Fucci cells expressed BFP in cell cycle phases other than the phases during
which infection occurred.
p53 is a key regulator that targets more than 150 genes associated with the
regulation of cell cycle arrest, apoptosis, and DNA repair (El-Deiry, 1998; Amundson
et al., 1998). As p53 is involved in antiviral innate immunity (it transactivates several
21
interferon-inducible genes) (Rivas et al., 2010), targeting and regulating p53 may be a
strategy for viral infection and replication (Sato et al., 2009; Querido et al., 2001;
Bhowmick et al., 2013; Sato and Tsurumi, 2013). During the later stage of SIN
infection, when capsid proteins were produced, p53 expression was down-regulated in
both HeLa and Vero cells, as well as human fibroblasts, but up-regulated in HSC-4
cells. The p53 protein in HeLa cells, human fibroblasts, and Vero cells is wild-type
p53, while the p53 in HSC-4 cells is a dominant-negative mutant that effectively
suppresses the function of p73 in apoptosis (Bergamaschi et al., 2003; Ichwan et al.,
2006). The unresolved mechanism underlying the up-regulation of mutant p53 in SIN-
infected HSC-4 cells might provide a clue to understanding the interaction between
SIN infection and p53.
In conclusion, SIN infection can affect the expression of cell cycle regulators and
drive cancer cells to accumulate in S phase. Affecting p53 expression during the later
stage of viral infection might also be a strategy to achieve the efficient replication of
SIN.
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Table 1. HeLa-Fucci and Vero-Fucci cells infected with TR339-BFP-2A
Cells Cell cycle phase
HeLa-Fucci Vero-Fucci
G1 S/G2/M total G1 S/G2/M total
Total including uninfected at 2
hpi (%)
237(40) 362(60) 599 186(51) 178(49) 364
Infected at 2 hpi (%) 89(41) 128(59) 217 109(57) 81(43) 190
Expressing BFP
Number of cells (%) 148(52) 134(48) 282 122(51) 116(49) 238
Number of clones (%) 89(41) 128(59) 217 90(47) 100(53) 190
Apoptosis (%) 150(53) 133(47) 283 128(53) 113(47) 241
30
Table 2. Kinetics of the SIN replication in HeLa-Fucci and Vero-Fucci cells, and the cell cycle phases at infection.
Length of interval Cell cycle phase at infection
HeLa-Fucci infected during Vero-Fucci infected during
G1 S/G2/M Mean G0/G1 S/G2/M Mean
BFP expression (h) 9.3*
(±2.0)
10.4*
(±2.7)
10.0
(±2.6)
8.9†
(±3.1)
10.2†
(±3.4)
9.6
(±3.3)
Apoptosis (h) 13.1**
(±2.4)
14.3**
(±3.0)
13.8
(±2.9)
13.7††
(±3.5)
14.7††
(±3.3)
14.3
(±3.4)
between BFP expression and
apoptosis (h)
3.8
(±1.3)
3.9
(±1.4)
3.8
(±1.4)
4.9
(±1.7)
4.5
(±1.4)
4.7
(±1.5)
Standard deviations are in parentheses.
* P < 0.0001; ** P < 0.005; † P < 0.005; †† P < 0.01 (all according to the Mann-Whitney U-test).
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Fig. 1. The effect of SIN infection on cell cycle progression. HeLa or Vero cells were
infected with 1 MOI of SIN and subjected to FACS analysis at the indicated hour
post-infection (hpi). (A) FACS analysis of mock-infected (Mock) and SIN-infected
(SIN) HeLa cells at 2, 4, 7, and 15 hpi. Percentages of cells in G0/G1, S, and G2/M are
shown. (B) The time course of proportions of mock- and SIN-infected cells in G0/G1,
S, and G2/M phases. (C) FACS analysis of mock-infected (Mock) and SIN-infected
(SIN) Vero cells at 2, 4, 7, and 14 hpi. Percentages of cells in G0/G1, S, and G2/M are
shown. (D) The time course of proportions of mock- and SIN-infected Vero cells in
G0/G1, S, and G2/M phases. Data presented are the mean of three independent
experiments. Error bars indicate standard error.
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Fig. 2. Western blots of mock- and SIN-infected HeLa cells assess the expression of
cell cycle regulator proteins. Total protein from SIN-infected (SIN) and mock-
infected (Mock) cells at 2, 4, 7, and 15 hours post-infection (hpi) were subjected to
Western blotting. (A) Western blots of the G1 phase regulators cyclin D1, CDK4, and
CDK6. (B) Western blots of the G1/S transition regulators cyclin E, CDK2, p-CDK2
(Thr160), Cdc25A, p21, and p53. The bars indicate the positions of cyclin E and
Cdc25A. (C) Western blots of cyclin A, as well as G2/M transition regulators cyclin
B1 and p-cdc2. β-actin was an internal marker for equivalent protein loading.
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Fig.3. Western blots of mock- and SIN-infected HeLa cells assess the expression of
capsid protein and pro-apoptotic proteins (caspase-3 and PARP). Total protein from
SIN-infected (SIN) and mock-infected (Mock) cells at 2, 4, 7, and 15 hours post-
infection (hpi) were subjected to Western blotting. The bars indicate the positions of
capsid, cleaved caspase-3, and PARP bands.
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Fig. 4. The replication of BFP-expressing SIN, TR339-BFP-2A, in HeLa-Fucci and
Vero-Fucci cells. Fucci labels nuclei orange during G1 phase and green during S/G2/M
phases. After infection with BFP-expressing SIN, TR339-BFP-2A, images of HeLa-
Fucci and Vero-Fucci cells were obtained at 30-min intervals with a computer-
assisted fluorescence microscope (Olympus, FV10i). Co-expression of blue
fluorescent protein (BFP) with structural proteins from TR339-BFP-2A was observed
in the cytoplasm. The lineage of each BFP-expressing cell was traced, and the cell
cycle phase during which TR339-BFP-2A infection took place was determined.
Arrows indicate cells that were infected during G1 and expressed BFP during G1 (A)
or S/G2 (B), cells that were infected during S/G2 and expressed BFP during S/G2 (C),
or G1 phase after cell division (D). The images shown were recorded at 2 hours post-
infection (2 hpi) and at the time of BFP expression (BFP+).
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Fig. 5. Cell-cycle kinetics of HeLa-Fucci (A) and Vero-Fucci (B) cells infected with
TR339-BFP-2A during G1 and S/G2 phase. Nuclei were labeled orange during G1 and
green during S/G2. The lineage of each BFP-expressing cell was traced, and the cell
cycle phase during which TR339-BFP-2A infection took place was determined (G1 or
S/G2). The numbers of the traced cells are shown. The intervals between infection and
BFP expression are shown at the right (BFP+). The distributions of BFP-expressing
cells in G1 and S/G2 differed significantly between HeLa-Fucci and Vero-Fucci cells
(§, P < 0.05, chi-square test). *P < 0.005; **P < 0.0001; †P < 0.005; ††P < 0.00001
(all according to the Mann-Whitney U-test).
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Fig. 6. Western blots of mock- and SIN-infected Vero cells (A), human fibroblasts
(B), and HSC-4 cells (C) to assess the expression of p53 and the capsid proteins. Total
protein was extracted from Vero, human fibroblast, and HSC-4 cells infected with
SIN (SIN) or mock-infected (Mock) at the indicated time post-infection (hours post-
infection, hpi) and were subjected to Western blotting with antibodies raised against
p53, capsid protein, and β-actin. β-actin was an internal marker for equivalent protein
loading. The bars indicate the positions of p53 and capsid.
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